01
Cash & equivalents decreased 7.4%
Cash & equivalents changed -7.4% from the comparable as-filed period.
$52.5M→$48.6MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTOlema Pharmaceuticals, Inc.'s latest supported as-filed period reports net income of -$63.2M, 44.3% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -7.4% from the comparable as-filed period.
Net income changed -44.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -40.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
OLMA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-347853SEC ↗10-QAug 10, 2026Period Jun 30, 20260001193125-26-342383SEC ↗8-KAug 10, 2026Period Aug 10, 20260001193125-26-342334SEC ↗4Jul 27, 2026Period Jul 23, 20260001831410-26-000008SEC ↗4Jun 23, 2026Period Jun 18, 20260000921895-26-001653SEC ↗4Jun 23, 2026Period Jun 18, 20260001831410-26-000006SEC ↗4Jun 23, 2026Period Jun 18, 20260001222082-26-000004SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +31.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +175.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001533228-26-000008